Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320138 · ClinicalTrials.gov registry record · Phase 1
Acupuncture for the Treatment of Posttraumatic Stress Among Military Personnel
A Phase 1 study of Posttraumatic Stress Disorder (PTSD), sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT00320138: Completed Phase 1 study of Posttraumatic Stress Disorder (PTSD), sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
NCT00320138 is a Phase 1 study of Posttraumatic Stress Disorder (PTSD) that has completed, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 55 participants, below the 110-participant average among 31 other Posttraumatic Stress Disorder (PTSD) trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00320138, a Phase 1 study of Posttraumatic Stress Disorder (PTSD), has completed, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effectiveness of acupuncture as a treatment for Posttraumatic Stress Disorder (PTSD) among military personnel.
Primary Outcome
The PCL is a widely used measure of PTSD symptom presence and severity among veterans. It is a 17-item measure that assesses the symptoms of PTSD listed in the DSM-IV. Respondents indicate on a 5-point scale (1-5) the degree to which they have been bothered by each symptom in the past month. The PCL-M yields a total severity score ranging from 17 to 85.
Conditions Studied
Interventions
- PROCEDURE Acupuncture, using Chinese Medicine methodology
Study Locations (1)
Maryland
- Deployment Health Clinical Center, WRNMMC/USUHS Dept. of Psychiatry - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-10 |
| Phase | Phase 1 |
What the finished NCT00320138 record still lists
NCT00320138 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 110-participant average among 31 other Posttraumatic Stress Disorder (PTSD) trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Posttraumatic Stress Disorder (PTSD) appearing as the primary indexed condition, and to 1 intervention - of which Acupuncture, using Chinese Medicine methodology is the first listed.
NCT00320138 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00320138 about?
NCT00320138 is a clinical study titled "Acupuncture for the Treatment of Posttraumatic Stress Among Military Personnel". The purpose of this study is to determine the effectiveness of acupuncture as a treatment for Posttraumatic Stress Disorder (PTSD) among military personnel.
What is the current status of trial NCT00320138?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 55 participants. The study started on 2006-03. Estimated completion is 2007-10.
What conditions does trial NCT00320138 study?
This clinical trial studies the following conditions: Posttraumatic Stress Disorder (PTSD).
What interventions are being tested in trial NCT00320138?
The interventions under investigation include: Acupuncture, using Chinese Medicine methodology (PROCEDURE).
Who is sponsoring clinical trial NCT00320138?
This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00320138 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Posttraumatic Stress Disorder (PTSD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00320138's enrollment target sits among peer trials
55 24th of 31 higher than 8 of 31 other Posttraumatic Stress Disorder (PTSD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Posttraumatic Stress Disorder (PTSD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Inflammatory Challenge and Fear
RECRUITING · Phase 1
-
Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
RECRUITING · Phase 1
-
A Clinical Trial for Post Traumatic Stress Disorder
COMPLETED · Phase 1
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
A Neurosensory Account of Anxiety and Stress (Study 2)
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia